| Symbol | BNPQF |
|---|---|
| Name | BNP PARIBAS |
| Sector | UNDEFINED |
| Region | Europe |
| Industry | - |
| Address | 75009 France 16 Boulevard des Italiens |
| Telephone | +33 1 42 98 12 34 |
| Fax | — |
| — | |
| Website | https://invest.bnpparibas/en/ |
| Incorporation | FR |
| Incorporated On | 1848 |
| Employees | — |
| Fiscal Year | 12/31 |
| Public Since | — |
| Exchanges | OTC |
| Auditor | Deloitte et Associes;Ernst & Young et Autres; |
| Audit Status | AUDITED |
| Reporting Status | International Reporting: Euronext Paris |
| CIK | 0000310732 |
| Description | Leader in banking and financial services in Europe, BNP Paribas operates in 64 countries and has nearly 178,000 employees, including more than 144,000 in Europe. The Group has key positions in its three main fields of activity: Commercial, Personal Banking & Services for the Group’s commercial & personal banking and several specialised businesses including BNP Paribas Personal Finance and Arval; Investment & Protection Services for savings, investment and protection solutions; and Corporate & Institutional Banking, focused on corporate and institutional clients. Based on its strong diversified and integrated model, the Group helps all its clients (individuals, community associations, entrepreneurs, SMEs, corporates and institutional clients) to realise their projects through solutions spanning financing, investment, savings and protection insurance. In Europe, BNP Paribas has four domestic markets: Belgium, France, Italy and Luxembourg. The Group is rolling out its integrated commercial & personal banking model across several Mediterranean countries, Türkiye, and Eastern Europe. As a key player in international banking, the Group has leading platforms and business lines in Europe, a strong presence in the Americas as well as a solid and fast-growing business in Asia-Pacific. BNP Paribas has implemented a CSR approach in all its activities, enabling it to contribute to the construction of a sustainable future, while ensuring the Groups performance and stability. Additional info from OTC: |
No news found.